PCB

DEVICE3 trials

Sponsors

Deutsches Herzzentrum Muenchen, Acotec Scientific Co., Ltd, Henan Cancer Hospital

Conditions

Chronic Limb-Threatening IschemiaCoronary RestenosisTNBC - Triple-Negative Breast Cancer

Phase 2

Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer

Not yet recruitingNCT07256964

Henan Cancer HospitalTNBC - Triple-Negative Breast Cancer

Start: 2025-11-26End: 2033-12-31Target: 216Updated: 2025-12-02

Unknown Phase

Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES

CompletedNCT02367495

Deutsches Herzzentrum MuenchenCoronary Restenosis

Start: 2015-01-31End: 2017-10-25Updated: 2019-01-08

AcoArt Litos PCB Below-the-knee Global Trial

RecruitingNCT06330493

Acotec Scientific Co., LtdChronic Limb-Threatening Ischemia

Start: 2024-10-10End: 2032-10-31Target: 288Updated: 2025-07-03

Related Papers

Comparative long‐term efficacy and safety of two paclitaxel‐coated balloons with different coating strategies for the treatment of drug‐eluting coronary stent restenosis

Catheterization and Cardiovascular Interventions2024-09-182 citations

A prospective trial of a novel <scp>low‐dose paclitaxel‐coated</scp> balloon therapy in patients with restenosis in <scp>drug‐eluting</scp> coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent <scp>In‐stent</scp> REstenosis <scp>3A</scp> (ISAR‐DESIRE 3A)

Catheterization and Cardiovascular Interventions2021-11-184 citations